Kadans Science Partner, the AXA IM-Alts-owned life sciences group, has added two more properties in King’s Cross in London to its burgeoning pan-European life sciences real estate portfolio.
Kadans Science Partner, the AXA IM-Alts-owned life sciences group, has added two more properties in King’s Cross in London to its burgeoning pan-European life sciences real estate portfolio.
Watch the video to learn how you can access industry leading CRE news and the data analytics you need to drive success.
This news story is available exclusively to CoStar subscribers.
Ready to Learn More?
Sign Up For a Personalized Demo.
Sign Up For a Demo To Learn More.
Already A Subscriber? Sign In
Real Estate